Steve Valiquette

Stock Analyst at Barclays

(1.46)
# 3,542
Out of 5,090 analysts
155
Total ratings
45.87%
Success rate
-3.54%
Average return

Stocks Rated by Steve Valiquette

Brookdale Senior Living
Nov 10, 2025
Maintains: Equal-Weight
Price Target: $8$9.5
Current: $10.78
Upside: -11.87%
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10$12
Current: $7.59
Upside: +58.10%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596$616
Current: $808.62
Upside: -23.82%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8$9
Current: $2.71
Upside: +232.10%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5$5
Current: $14.10
Upside: -64.54%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12$10
Current: $5.48
Upside: +82.48%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25$24
Current: $17.40
Upside: +37.93%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89$86
Current: $75.63
Upside: +13.71%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86$85
Current: $38.34
Upside: +121.70%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275$300
Current: $486.70
Upside: -38.36%
Maintains: Underweight
Price Target: $35$34
Current: $35.18
Upside: -3.35%
Maintains: Overweight
Price Target: $70$105
Current: $210.00
Upside: -50.00%
Maintains: Overweight
Price Target: $57$55
Current: $80.61
Upside: -31.77%
Maintains: Equal-Weight
Price Target: $15$13
Current: $19.28
Upside: -32.57%
Upgrades: Equal-Weight
Price Target: $132$142
Current: $231.08
Upside: -38.55%
Maintains: Underweight
Price Target: $13$5
Current: $30.79
Upside: -83.76%
Initiates: Equal-Weight
Price Target: $57
Current: $112.50
Upside: -49.33%
Maintains: Overweight
Price Target: $78$82
Current: $204.31
Upside: -59.86%
Maintains: Overweight
Price Target: $20$18
Current: $17.02
Upside: +5.76%
Maintains: Equal-Weight
Price Target: $33$31
Current: $45.73
Upside: -32.21%
Maintains: Overweight
Price Target: $400$375
Current: $151.86
Upside: +146.94%
Maintains: Equal-Weight
Price Target: $20$19
Current: $37.70
Upside: -49.60%
Maintains: Overweight
Price Target: $500$570
Current: $257.85
Upside: +121.06%
Downgrades: Equal-Weight
Price Target: $70$64
Current: $198.83
Upside: -67.81%
Maintains: Overweight
Price Target: $275$310
Current: $265.44
Upside: +16.79%
Maintains: Overweight
Price Target: $495$565
Current: $330.91
Upside: +70.74%
Downgrades: Equal-Weight
Price Target: $150$75
Current: $3.03
Upside: +2,375.25%
Upgrades: Overweight
Price Target: $26$19
Current: $5.03
Upside: +277.73%
Maintains: Underweight
Price Target: $6$10
Current: $3.57
Upside: +180.11%
Initiates: Overweight
Price Target: $20
Current: $9.31
Upside: +114.82%
Reinstates: Overweight
Price Target: $260
Current: $88.01
Upside: +195.42%